Results 181 to 190 of about 3,470 (308)
Time Trends and Predictors of Gout Remission Over 6 Years
Objective This study aims to describe the trends in remission rates over 6 years of follow‐up among people with gout taking urate‐lowering therapy (ULT) and to identify variables that predict remission. Methods A post hoc analysis was conducted using data from the Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout (CARES) trial ...
Adwoa Dansoa Tabi‐Amponsah +5 more
wiley +1 more source
Acoustic modes in M67 cluster stars trace deepening convective envelopes. [PDF]
Reyes C +5 more
europepmc +1 more source
Objective Systemic sclerosis (SSc) is a rare autoimmune disease characterized by tissue fibrosis, vasculopathy, and immune dysregulation. Our objectives were to quantify the overall and site‐specific cancer risks in patients with SSc compared to the general population, examine temporal trends in cancer incidence following SSc diagnosis, and explore ...
Jihyun Na +4 more
wiley +1 more source
Nucleosynthesis in Massive Stars with Improved Nuclear and Stellar Physics [PDF]
T. Rauscher +3 more
openalex +1 more source
Evidence of star cluster migration and merger in dwarf galaxies. [PDF]
Poulain M +10 more
europepmc +1 more source
Atomic Physics Data for Stellar Atmospheres Research [PDF]
Charles R. Cowley +2 more
openalex +1 more source
Objective We assessed whether shared decision‐making (SDM) and patient acceptability, feasibility, and overall satisfaction with a computerized patient decision aid (PtDA) for patients with systemic lupus erythematosus (SLE) differs by PtDA setting, modality, and the viewing experience. Methods Patients with SLE were invited to view a self‐administered
Jasvinder A. Singh +20 more
wiley +1 more source
Strong gravitational lenses from the Vera C. Rubin Observatory. [PDF]
Shajib AJ +8 more
europepmc +1 more source
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang +4 more
wiley +1 more source

